Welcome to the e-CCO Library!

P028: Transitioning patients from intravenous to subcutaneous infliximab and vedolizumab for inflammatory bowel disease – what is the opportunity cost of improving access to health care?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Hilley, P.(1,2)*;Wong, D.(1,3);Ma, R.(4);Peterson, A.(1);De Cruz, P.(1,3);
Created: Friday, 14 July 2023, 10:48 AM
P029 TRIM 21 protects against ulcerative colitis and colitic cancer via smad7 inhibition
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K.B. Hahm

Created: Thursday, 30 January 2020, 10:12 AM
P0290: Predicting disease remission in Ulcerative Colitis patients - early results from the PRESAGER study
Year: 2025
Source: ECCO'25
Authors: Nordestgaardx7x7x7 R.L.M.(1x7x7x72)*;Lox7x7x7 B.(1x7x7x72);Bergstrømx7x7x7 R.(1);Adzioskix7x7x7 I.(1);Nielsenx7x7x7 H.S.(1);Hawwax7x7x7 I.M.(1);Holmex7x7x7 S.K.(1);Tiftikcix7x7x7 B.(1);Majchrzakx7x7x7 K.(1);Vindx7x7x7 I.(1x7x7x72x7x7x73);Bendtsenx7x7x7 F.(1x7x7x72x7x7x73);Burischx7x7x7 J.(1x7x7x72x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0291: Tailoring Crohn’s disease surveillance after ileocolic resection: the importance of inflammatory biomarkers
Year: 2025
Source: ECCO'25
Authors: Ferreirax7x7x7 A.I.(1x7x7x72x7x7x73)*;Lima Capelax7x7x7 T.(1x7x7x72x7x7x73);Xavierx7x7x7 S.(1x7x7x72x7x7x73);Arieirax7x7x7 C.(1x7x7x72x7x7x73);Cotterx7x7x7 J.(1x7x7x72x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0292: CD8+ Cell Dominance in Immune Checkpoint Inhibitor-Induced Colitis and Its Heterogeneity Across Endoscopic Features
Year: 2025
Source: ECCO'25
Authors: Hwangx7x7x7 S.W.(1)*;Kimx7x7x7 M.K.(1);Sonx7x7x7 H.N.(2);Hongx7x7x7 S.W.(1);Parkx7x7x7 S.H.(1);Yangx7x7x7 D.H.(1);Yex7x7x7 B.D.(1);Byeonx7x7x7 J.S.(1);Myungx7x7x7 S.J.(1);Yangx7x7x7 S.K.(1);Yoonx7x7x7 S.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0293: The utility of small bowel capsule endoscopy in Crohn’s Disease – a retrospective cohort study
Year: 2025
Source: ECCO'25
Authors: Yeox7x7x7 J.H.(1)*;Ramanx7x7x7 K.(1);Willaimsx7x7x7 S.(1);Villax7x7x7 M.(1);Willsmorex7x7x7 J.(1);Bloomx7x7x7 S.(1);McCartneyx7x7x7 S.(1);Harrowx7x7x7 P.(1);Kabirx7x7x7 M.(1);Sewardx7x7x7 E.(1);Parisix7x7x7 I.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0294: Functional outcomes after primary ileocecal resection for Crohn’s disease
Year: 2025
Source: ECCO'25
Authors: Grellierx7x7x7 N.(1)*;Kirchgesnerx7x7x7 J.(1);Chafaix7x7x7 N.(2);Nion-Larmurierx7x7x7 I.(1);Debovex7x7x7 C.(2);Bourrierx7x7x7 A.(1);landmanx7x7x7 C.(1);Mclellanx7x7x7 P.(1);Sokolx7x7x7 H.(1);Beaugeriex7x7x7 L.(1);Lefèvrex7x7x7 J.H.(2);Seksikx7x7x7 P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0295: Histological healing reduces the risk of relapse in ulcerative colitis: results of a prospective study
Year: 2025
Source: ECCO'25
Authors: Yzetx7x7x7 C.(1)*;Robertx7x7x7 C.(1);Brazierx7x7x7 F.(1);Meudjox7x7x7 E.(1);Moreaux7x7x7 C.(1);Chatelainx7x7x7 D.(2);Fumeryx7x7x7 M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0296: Comparison of clinical characteristics of Montreal classification group A3 patients with Crohn’s disease in Korea: Results from the Prospective and Retrospective CONNECT Study
Year: 2025
Source: ECCO'25
Authors: Yoonx7x7x7 J.(1)*;Kimx7x7x7 Y.S.(1);Yex7x7x7 B.D.(2);Cheonx7x7x7 J.H.(3);Imx7x7x7 J.P.(4);Joo Sung x7x7x7 K.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0297: Development of Red Flags Index for Crohn’s Disease in the Korean population
Year: 2025
Source: ECCO'25
Authors: Kimx7x7x7 O.(1)*;Kimx7x7x7 S.H.(1);Leex7x7x7 H.J.(1);Imx7x7x7 J.P.(1);Kimx7x7x7 B.G.(1);Kimx7x7x7 J.S.(1);Kohx7x7x7 S.J.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0298: Revolutionizing Diagnostics: Evaluating ChatGPT-4's Performance in Ulcerative Colitis Endoscopic Assessment
Year: 2025
Source: ECCO'25
Authors: Levartovskyx7x7x7 A.(1)*;Albsheshx7x7x7 A.(1);Grinmanx7x7x7 A.(1);Shacharx7x7x7 E.(1);Lahatx7x7x7 A.(1);Eliakimx7x7x7 R.(1);Kopylovx7x7x7 U.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0299: Luminal phenotype of Crohn's disease: the effectiveness of ultrasound compression elastography in the early diagnosis of disease recurrence.
Year: 2025
Source: ECCO'25
Authors: Iakovlevx7x7x7 A.A.(1)*;Palenyix7x7x7 A.(2);Nelasovx7x7x7 N.(3);Tarasovax7x7x7 G.(4);Volkovx7x7x7 A.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P029: Activation of FXR restores expression of genes dysregulated in human IBD and suppresses TNFa and IL-6 signaling pathways in adoptive transfer colitis model
Year: 2021
Source: ECCO'21 Virtual
Authors: Liu, X.(1);Milik, A.(1);O'Connell, R.(2);White, J.(2);Wagner, B.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P029: Azelnidipine, a novel calcium channel blocker, ameliorates severity of colitis in DSS induced colitis in mice possibly by modulating tissue levels of TNF-alpha and IL-6
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kav T., Akyol A., Aksoy E., Ozer C., Torgutalp M., Sivri B.

Created: Wednesday, 20 February 2019, 10:36 AM
P029: Expression of miR-21 in mucosal biopsies give clues to anti-TNF treatment non-response in IBD children and adults
Year: 2022
Source: ECCO'22
Authors: Pallikkunnath James, J.(1);Schnack Nielsen, B.(2);Langholz, E.(3,4);Mikkel , M.(5,6,7);Estrid , H.(1);Buhl Riis, L.(8);
Created: Friday, 11 February 2022, 3:52 PM
P029: Histopathological characterization of a chronic DSS-induced mouse model of IBD with intestinal fibrosis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Nielsen, M.H.(1)*;Zachariassen, L.F.(1);Sárvári, A.K.(2);Marstrand-Jørgensen, A.B.(3);Hansen, H.H.(4);Feigh, M.(4);
Created: Friday, 14 July 2023, 10:48 AM
P029: Intestinal mesenchymal-specific IKK2 promotes initiation of colitis and colitis-associated cancer
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

V. Koliaraki*1, M. Pasparakis2, G. Kollias1, 3

Created: Friday, 22 February 2019, 9:49 AM
P029: Modulation of intestinal epithelial permeability by plasma from patients with Crohn’s disease in a 3D cell culture model
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Xu*, E. Elamin, M. Elizalde, P. Bours, M. Pierik, A. Masclee, D. Jonkers

Created: Thursday, 21 February 2019, 9:14 AM
P029: Serum bile acids profiling in IBD patients treated with anti-TNFs
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Roda*1, E. Porru2, K. Katsanos3, A. Skamnelos3, K. Kyriakidi3, D. K. Christodoulou3, C. Caliceti2, G. Fiorino1, S. Danese1, A. Roda2

Created: Friday, 22 February 2019, 9:41 AM
P030 Dynamics of intestinal inflammation and microbial dysbiosis in pregnant women with IBD and their infants
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Tarassishin PhD1, E. Kim2, C. Eisele1, A. Barre3, A. Thjømøe4, E. Mørk4, M. Dubinsky5, J. Stone6, N. Nair1, A. Debebe1, K. Hawkins1, A. Rendon1, J. Sabino7, J. Torres8, J.F. Colombel9, I. Peter1, J. Hu1

Created: Thursday, 30 January 2020, 10:12 AM